{"id":702,"date":"2023-10-26T11:27:40","date_gmt":"2023-10-26T15:27:40","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/rxpidresources\/chapter\/heart-failure-2\/"},"modified":"2023-11-11T22:38:30","modified_gmt":"2023-11-12T03:38:30","slug":"heart-failure-2","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/rxpidresources\/chapter\/heart-failure-2\/","title":{"raw":"Heart Failure","rendered":"Heart Failure"},"content":{"raw":"
\r\n
In this chapter, you will find Canadian guidelines for both acute and chronic management of heart failure. We have also provided you with links to scoring tools to assess a patient\u2019s risk of mortality and hospitalization followed by relative benefit patients will receive with certain drug therapies.<\/div>\r\n<\/div>\r\n

Student Resources<\/h2>\r\nChronic Heart Failure One Pager<\/a>\r\n

Tools<\/h1>\r\n
MAGGIC Risk Calculator<\/em><\/span><\/summary>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Purpose<\/strong><\/td>\r\nAssess the risk of mortality at year 1 and 3 in patients with.<\/td>\r\n<\/tr>\r\n
Type of Resource<\/strong><\/td>\r\nScoring tool<\/td>\r\n<\/tr>\r\n
Included<\/strong><\/td>\r\n\r\n
    \r\n \t
  • Tool consists of risk factors associated with mortality in heart failure.<\/li>\r\n \t
  • By selecting a drug therapy you want to start your patient on (ie. ACEI\/BB), the tool will provide the patients new risk of mortality in 1 and 3 years.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n
Student Bottom Line<\/strong><\/td>\r\nUse this scoring tool to assess the risks and benefits to starting patients on recommended heart failure drug therapy.<\/td>\r\n<\/tr>\r\n
VIEW RESOURCE<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/details>
BCN Bio-HF Calculator<\/em><\/span><\/summary>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Purpose<\/strong><\/td>\r\nAssess the risk of mortality and hospitalization at 1-5 years in patients with heart failure. This tool then determines the relative benefit patients will receive if started on recommended drug therapy.<\/td>\r\n<\/tr>\r\n
Type of Resource<\/strong><\/td>\r\nScoring tool<\/td>\r\n<\/tr>\r\n
Included<\/strong><\/td>\r\n\r\n
    \r\n \t
  • Tool consists of risk factors associated with mortality and hospitalization in heart failure.<\/li>\r\n \t
  • By selecting a drug therapy you want to start your patient on (ie. ACEI\/BB), the tool will provide the patients new risk of mortality and hospitalization at years 1 to 5.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n
Student Bottom Line<\/strong><\/td>\r\nUse this scoring tool to assess the risks and benefits to starting patients on recommended heart failure drug therapy.<\/td>\r\n<\/tr>\r\n
VIEW RESOURCE<\/a>\r\n<\/strong><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/details>\r\n

Guidelines<\/h1>\r\n
The Canadian Cardiovascular Society \u2013 Acute Heart Failure Guidelines<\/em><\/span><\/summary>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Purpose<\/strong><\/td>\r\nGuide treatment recommendations for patients presenting with acute heart failure.<\/td>\r\n<\/tr>\r\n
Type of Resource<\/strong><\/td>\r\nSummarized guidelines<\/td>\r\n<\/tr>\r\n
Included<\/strong><\/td>\r\n\r\n
    \r\n \t
  1. Diagnosis\/ Investigations<\/li>\r\n \t
  2. Treatment algorithms<\/li>\r\n \t
  3. Dosing recommendations<\/li>\r\n<\/ol>\r\n<\/td>\r\n<\/tr>\r\n
Student Bottom Line<\/strong><\/td>\r\nThe preferred resource to guide treatment for patients in acute heart failure. The recommendations are very concise and algorithms are simple to read. For more details and information, the full guidelines are preferred.<\/td>\r\n<\/tr>\r\n
VIEW RESOURCE (full guidelines)<\/a>- VIEW RESOURCE (pocket guidelines)<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/details>
The Canadian Cardiovascular Society \u2013 Chronic Heart Failure Guidelines<\/em><\/span><\/summary>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Purpose<\/strong><\/td>\r\nGuide treatment recommendations for patients with longstanding heart failure<\/td>\r\n<\/tr>\r\n
Type of Resource<\/strong><\/td>\r\nSummarized guidelines<\/td>\r\n<\/tr>\r\n
Included<\/strong><\/td>\r\n\r\n
    \r\n \t
  • Pharmacological recommendations for both [pb_glossary id=\"261\"]HFrER[\/pb_glossary] and [pb_glossary id=\"59\"]HFpEF[\/pb_glossary]<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n
Student Bottom Line<\/strong><\/td>\r\nThe preferred resource to guide treatment for patients in acute heart failure. The recommendations are very concise and algorithms are simple to read. For more details and information, the full guidelines are preferred.<\/td>\r\n<\/tr>\r\n
VIEW RESOURCE (full guidelines)<\/a> - VIEW RESOURCE (pocket guidelines)<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/details>","rendered":"
\n
In this chapter, you will find Canadian guidelines for both acute and chronic management of heart failure. We have also provided you with links to scoring tools to assess a patient\u2019s risk of mortality and hospitalization followed by relative benefit patients will receive with certain drug therapies.<\/div>\n<\/div>\n

Student Resources<\/h2>\n

Chronic Heart Failure One Pager<\/a><\/p>\n

Tools<\/h1>\n
\nMAGGIC Risk Calculator<\/em><\/span><\/summary>\n\n\n\n\n\n\n\n
Purpose<\/strong><\/td>\nAssess the risk of mortality at year 1 and 3 in patients with.<\/td>\n<\/tr>\n
Type of Resource<\/strong><\/td>\nScoring tool<\/td>\n<\/tr>\n
Included<\/strong><\/td>\n\n
    \n
  • Tool consists of risk factors associated with mortality in heart failure.<\/li>\n
  • By selecting a drug therapy you want to start your patient on (ie. ACEI\/BB), the tool will provide the patients new risk of mortality in 1 and 3 years.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
Student Bottom Line<\/strong><\/td>\nUse this scoring tool to assess the risks and benefits to starting patients on recommended heart failure drug therapy.<\/td>\n<\/tr>\n
VIEW RESOURCE<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/details>\n
\nBCN Bio-HF Calculator<\/em><\/span><\/summary>\n\n\n\n\n\n\n\n
Purpose<\/strong><\/td>\nAssess the risk of mortality and hospitalization at 1-5 years in patients with heart failure. This tool then determines the relative benefit patients will receive if started on recommended drug therapy.<\/td>\n<\/tr>\n
Type of Resource<\/strong><\/td>\nScoring tool<\/td>\n<\/tr>\n
Included<\/strong><\/td>\n\n
    \n
  • Tool consists of risk factors associated with mortality and hospitalization in heart failure.<\/li>\n
  • By selecting a drug therapy you want to start your patient on (ie. ACEI\/BB), the tool will provide the patients new risk of mortality and hospitalization at years 1 to 5.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
Student Bottom Line<\/strong><\/td>\nUse this scoring tool to assess the risks and benefits to starting patients on recommended heart failure drug therapy.<\/td>\n<\/tr>\n
VIEW RESOURCE<\/a>
\n<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/details>\n

Guidelines<\/h1>\n
\nThe Canadian Cardiovascular Society \u2013 Acute Heart Failure Guidelines<\/em><\/span><\/summary>\n\n\n\n\n\n\n\n
Purpose<\/strong><\/td>\nGuide treatment recommendations for patients presenting with acute heart failure.<\/td>\n<\/tr>\n
Type of Resource<\/strong><\/td>\nSummarized guidelines<\/td>\n<\/tr>\n
Included<\/strong><\/td>\n\n
    \n
  1. Diagnosis\/ Investigations<\/li>\n
  2. Treatment algorithms<\/li>\n
  3. Dosing recommendations<\/li>\n<\/ol>\n<\/td>\n<\/tr>\n
Student Bottom Line<\/strong><\/td>\nThe preferred resource to guide treatment for patients in acute heart failure. The recommendations are very concise and algorithms are simple to read. For more details and information, the full guidelines are preferred.<\/td>\n<\/tr>\n
VIEW RESOURCE (full guidelines)<\/a>– VIEW RESOURCE (pocket guidelines)<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/details>\n
\nThe Canadian Cardiovascular Society \u2013 Chronic Heart Failure Guidelines<\/em><\/span><\/summary>\n\n\n\n\n\n\n\n
Purpose<\/strong><\/td>\nGuide treatment recommendations for patients with longstanding heart failure<\/td>\n<\/tr>\n
Type of Resource<\/strong><\/td>\nSummarized guidelines<\/td>\n<\/tr>\n
Included<\/strong><\/td>\n\n
    \n
  • Pharmacological recommendations for both HFrER and HFpEF<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
Student Bottom Line<\/strong><\/td>\nThe preferred resource to guide treatment for patients in acute heart failure. The recommendations are very concise and algorithms are simple to read. For more details and information, the full guidelines are preferred.<\/td>\n<\/tr>\n
VIEW RESOURCE (full guidelines)<\/a> – VIEW RESOURCE (pocket guidelines)<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/details>\n
definition<\/span>